Evidence map›Paper›PMID 41088074›Full record

ArticleBMC public health2025

Incidence trends of different cancers attributable to smoking and alcohol consumption in Liaoning Province, Northeastern China from 2008 to 2019.

Li Liu, Qian Ren, Yu Zhang, Ruoyan Yue, Huijuan Mu, Yanxia Li, Huanliang Li, Yuehua Wang, Hongfeng Li, Jingying Li and 3 more

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Li Liu *Institute of Preventive Medicine, China Medical University, Shenyang, 110122, People's Republic of China.
Qian Ren *Key Laboratory of Environmental Stress and Chronic Disease Control & Prevention, Medical University, Ministry of Education, Shenyang, 110122, People's Republic of China.
Yu Zhang *Key Laboratory of Environmental Stress and Chronic Disease Control & Prevention, Medical University, Ministry of Education, Shenyang, 110122, People's Republic of China.
Ruoyan Yue *Key Laboratory of Environmental Stress and Chronic Disease Control & Prevention, Medical University, Ministry of Education, Shenyang, 110122, People's Republic of China.
Huijuan MuInstitute of Preventive Medicine, China Medical University, Shenyang, 110122, People's Republic of China.
Yanxia LiInstitute of Preventive Medicine, China Medical University, Shenyang, 110122, People's Republic of China.
Huanliang LiKey Laboratory of Environmental Stress and Chronic Disease Control & Prevention, Medical University, Ministry of Education, Shenyang, 110122, People's Republic of China.
Yuehua WangKey Laboratory of Environmental Stress and Chronic Disease Control & Prevention, Medical University, Ministry of Education, Shenyang, 110122, People's Republic of China.
Hongfeng LiDepartment of Healthcare, The First Hospital of China Medical University, Shenyang, 110001, People's Republic of China.
Jingying LiDepartment of Health Management, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China.
Chen LiStrategy and Operation Department, China Resources Healthcare Group Limited (CR Healthcare), Beijing, 100010, People's Republic of China.
Wei SunKey Laboratory of Environmental Stress and Chronic Disease Control & Prevention, Medical University, Ministry of Education, Shenyang, 110122, People's Republic of China. wsun@cmu.edu.cn.
Guowei PanKey Laboratory of Environmental Stress and Chronic Disease Control & Prevention, Medical University, Ministry of Education, Shenyang, 110122, People's Republic of China. gwpan@cmu.edu.cn.

Funding

the Key Laboratory Program of Shenyang City 21-103-0-16the Liaoning Revitalization Talents Program XLYC1802131the Science and Technology Innovation Team Project of China Medical University 2022 CXTD2022006
6 · The paper itself

Abstract

objectiveTo analyze the trends in cancer burden attributable to smoking and alcohol consumption in Liaoning Province from 2008 to 2019. 

methodsData on smoking and alcohol consumption were obtained from the Liaoning Provincial Chronic Disease and Behavioral Risk Factor Surveillance. Cancer incidence data were sourced from the Liaoning Province Cancer Registry Reporting System. We calculated the population attributable fraction (PAF) and age-standardized incidence rate (ASIR) for cancers attributable to smoking, alcohol consumption, and the combined effects of both. 

resultsIn 2019, the PAFm attributable to smoking, alcohol consumption, and their combination in males in Liaoning Province were 38.68% (95% CI 25.37–50.22), 10.91% (95% CI 3.87–19.31), and 32.81% (95% CI 20.73–43.37), respectively, while the corresponding values in females were 8.73% (95% CI 3.03–17.99), 0.68% (95% CI 0.10–2.02), and 8.87% (95% CI 3.03–18.42), respectively. Among cancers attributable to smoking, lung cancer had the highest PAFm in both males and females. Among cancers attributable to alcohol consumption, oropharyngeal cancer had the highest PAFm. The ASIRs attributable to smoking, alcohol consumption, and their combination in males were 99.14 per 100,000 (95% CI 64.87-128.86), 14.95 per 100,000 (95% CI 5.32–26.48), and 110.45 per 100,000 (95% CI 69.33-147.05), respectively, while the values in females were 14.06 per 100,000 (95% CI 4.74–29.56), 0.42 per 100,000 (95% CI 0.06–1.24), and 14.46 per 100,000 (95% CI 4.80–30.70), respectively. Lung cancer had the highest ASIR among cancers attributable to smoking in both genders, while colorectal cancer had the highest ASIR among cancers attributable to alcohol consumption in both genders. 

conclusionsThe cancer burden attributable to smoking and alcohol consumption remains high. Future health policy formulation needs to consider these factors more comprehensively and implement targeted interventions.

Indexed as

Alcohol DrinkingNeoplasmsSmokingAdultBehavioral Risk Factor Surveillance SystemChinaFemaleHumansIncidenceMaleMiddle AgedRegistriesAge-standardized incidence rate (ASIR).Alcohol consumptionCancerPopulation attributable fraction (PAF)Smoking

Identifiers

PMID41088074
PMCPMC12523210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.